APA (7th ed.) Citation

TJ, O., S, B., QJ, H., AL, S., S, Y., & V, B. (2020). Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial. Epilepsia, 61(4), 636. https://doi.org/10.1111/epi.16484

Chicago Style (17th ed.) Citation

TJ, O'Brien, Borghs S, He QJ, Schulz AL, Yates S, and Biton V. "Long-term Safety, Efficacy, and Quality of Life Outcomes with Adjunctive Brivaracetam Treatment at Individualized Doses in Patients with Epilepsy: An Up to 11-year, Open-label, Follow-up Trial." Epilepsia 61, no. 4 (2020): 636. https://doi.org/10.1111/epi.16484.

MLA (9th ed.) Citation

TJ, O'Brien, et al. "Long-term Safety, Efficacy, and Quality of Life Outcomes with Adjunctive Brivaracetam Treatment at Individualized Doses in Patients with Epilepsy: An Up to 11-year, Open-label, Follow-up Trial." Epilepsia, vol. 61, no. 4, 2020, p. 636, https://doi.org/10.1111/epi.16484.